TrialVaccine2016

Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.

Hana Hakim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.